https://www.selleckchem.com/products/pfk158.html
8 (95% CI 0.27-1.31) p less then 0.001]; CARE Measure [1.0 (95% CI 0.45-1.55) p less then 0.001], POSITIVE OUTCOMES [0.7 (95% CI 0.17-1.23) p less then 0.001]. Post-trial interviews revealed general acceptability of the intervention. The results confirm the feasibility and justify a definitive cRCT of the enhanced care intervention to improve person-centred outcomes for PLWH.Trial registration number ISRCTN13630241.RATIONALE Individuals eligible for lung cancer screening (LCS) by low-dose computed tomography (LDCT) are also at risk
Respect!
Kommentar
Delen
